Skip to content

ADARx Pharmaceuticals, Inc.

ADRX· Nasdaqxbrl foundCIK 1802369

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · +12.49%
Market cap
$1.65B
111.19M shares
Filings
51
$2.22M
Q3 2026
—
-$28.12M
Q3 2026
—
-$32.18M
Q3 2026
—
-$77.39M
Q3 2026derived
—
-$1.74
Q3 2026
—
$570.61M
Q3 2026+373.9% FY25 yoy
$1.65B
—
—
2.9×
—
—

FY2026 figures · derived

Price

$14.8623.20%$4.49since Sep 25, 2026
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$2.22MQ3 2026
No annual history for this metric yet.
PeriodEndedValueKindSource trail

Pharmaceutical preparations

ADARx Pharmaceuticals, Inc. is the 108th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

ADARx Pharmaceuticals, Inc. · CIK 1802369 · Engraved from SEC EDGAR